Brendan Luu

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ENTA

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Enanta Pharmaceuticals Inc (ENTA)	Chief Business Officer	$436,075	—	$1,034,100	$920,716	$166,183	$20,598	$2,577,672
2022	Enanta Pharmaceuticals Inc (ENTA)	Chief Business Officer	$411,300	—	$739,664	$985,114	$158,066	$19,424	$2,313,568
2021	Enanta Pharmaceuticals Inc (ENTA)	Chief Business Officer	$254,795	$75,000	$296,203	$1,757,805	$119,813	$1,350	$2,504,966
2020	Enanta Pharmaceuticals Inc (ENTA)	Senior Vice President, Business Development	—	—	—	—	—	—	—
2019	Enanta Pharmaceuticals Inc (ENTA)	Senior Vice President, Business Development	—	—	—	—	—	—	—

No earnings-call appearances or filed executive changes recorded yet.